Home » Topics » BioWorld Science

BioWorld Science
RSS

Prozac for infectious disease

June 17, 2020

Lifespan synaptic atlas gives developmental insights

June 17, 2020

FDA approves Lyumjev for type 1 and type 2 diabetes

June 16, 2020

Phase IIb study of lanifibranor in NASH meets primary and key secondary endpoints

June 16, 2020

Janssen plans phase II development of JNJ-40411813 for epilepsy

June 16, 2020

FDA grants accelerated approval to Zepzelca for metastatic SCLC

June 16, 2020

Favorable safety, pharmacodynamic activity seen with FT-4202 in phase I study

June 16, 2020

The Treg-selective long-acting IL-2 variant CUG-252 reduces inflammation in vitro and in vivo

June 16, 2020

Janssen discovers compounds active against respiratory syncytial virus

June 16, 2020

New dual CDK-HDAC inhibitors synthesized at Hangzhou Innogate Pharma

June 16, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...